Speaking at an event at the National Republican Congressional Committee, Trump said the tariff will incentivize drug companies to move their operations to the US.
The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.
Last month, at least two meetings were held between representatives of India & European Free Trade Association. The FTA with the 4-nation bloc is likely to be finalised this month.
Rs 6.4 cr worth of Remdesivir was sold in November, and Rs 12 cr in December, compared to Rs 287 cr in April 2021. Doctors say milder cases and better understanding is reason why.
PLI scheme is supposed to end India’s dependence on Chinese imports, but drug lobby says firms could end up dependent on one company for a molecule, increasing patients’ bills.
Based on the findings, researchers from ETH Zurich have said people should not keep popping paracetamol tablets if the recommended dose fails to ease their pain.
Drugmakers have also requested the government to consider ‘essentiality’ of the drug, and not its ‘turnover’, as the criterion for inclusion under NLEM.
The photo company is attempting to enter a low-margin commodity market with no particular advantage outside of the Trump administration's industrial policy.
Barring her first two Budgets, Nirmala Sitharaman has always ended the year with either a lower fiscal deficit figure than what she had projected or by adhering to the target.
MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
COMMENTS